Tenofovir alafenamide fumarate tablets (Vemlidy) latest price trend analysis in 2025

Tenofovir alafenamide fumarate tablets (Vemlidy, trade name: Vemlidy) is an antiviral drug used to treat chronic hepatitis B. Its main ingredient is tenofovir alafenamide fumarate. The drug is already on the market in China and has been included in medical insurance, making it highly accessible.

In the Chinese market, the price of tenofovir alafenamide fumarate tablets of 25mg*30 tablets is approximately RMB300. This price is competitive compared with other similar drugs, especially when covered by medical insurance, which reduces the financial burden on patients.

In addition, generic versions of tenofovir alafenamide fumarate tablets are also available in overseas markets, mainly from countries such as India and Laos. The prices of these generic drugs are relatively low, ranging from RMB 100 to RMB 200. It should be noted that although the ingredients of these generic drugs are basically the same as those of the original drugs, there may be differences in their production processes and quality control. Patients should be cautious when choosing and use them under the guidance of a doctor.

Overall, the price of tenofovir alafenamide fumarate tablets in the Chinese market is relatively reasonable, and the coverage of medical insurance further reduces the treatment cost for patients. For patients with limited financial conditions, overseas generic drugs provide another option, but their quality and safety should be fully understood before use. When choosing drugs, patients should make the most appropriate decision based on their own circumstances and doctor's recommendations.

Reference link:https://www.drugs.com